Document is current
Any future updates will be listed below
-
Authors
Meganck, Rita M. https://orcid.org/0000-0003-2799-3754
Baric, Ralph S. https://orcid.org/0000-0001-6827-8701
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI108197)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI132178)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI157155)
- License Information
-
More Information
Article History
Received: 25 January 2021
Accepted: 8 February 2021
First Online: 15 March 2021
Competing interests
: R.S.B. has competing interests regarding collaborative research with Gilead Sciences, Ridgeback Biotherapeutics, Takeda, Pfizer, Eli Lily, Adimab and Moderna Therapeutics.
